486 High Plain St
Walpole, MA 02081
Phone: (508) 668-7600
Patient Safety | Patient Guide | Privacy Policy | Terms of Use | Contact Us | Site Map | RADIESSE-FL | RADIESSE® Voice EM00233-04
Manufactured by Merz Aesthetics, Inc.
Copyright © Merz Aesthetics, Inc. All rights reserved.
The Merz Aesthetics logo is a trademark of Merz Pharma GmbH & Co. KGaA.
RADIESSE is a registered trademark of Merz Aesthetics, Inc
Important RADIESSE Volumizing Filler Treatment Considerations
RADIESSE Volumizing Filler is FDA-approved for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. After injection, patients may experience redness, bruising, swelling or other local side effects. Most side effects of treatment resolve within a few days. More rare side effects may include swelling that lasts longer, unevenness or firmness in the area injected, and as with any injection, there may be a risk of infection.
1 Berlin A, Hussain M, Goldberg D. (2008) Calcium Hydroxylapatite Filler for Facial Rejuvenation: A Histologic and Immunohistochemical Analysis. Dermatologic Surgery, Volume 34, S64-S67.
2 Bass LS, Smith S, Busso M, McClaren M. (2010) Calcium Hydroxylapatite (Radiesse) for Treatment of Nasolabial Folds: Long-Term Safety and Efficacy Results, Aesthetic Surgery Journal, 30 (2), 235-238.
3 Moers-Carpi MM, Opi Tufet J. Calcium Hydroxylapatite (RADIESSE®) versus Nonanimal Stabilized Hyaluronic Acid (Restylane®) for the Correction of Nasolabial Folds: a 60 patient, 12-Month, Multicenter, Prospective, Randomized, Controlled, Split-Face Trial. Dermatol Surg 2008;34: 210-215.
4 Moers-Carpi M, Vogt S, Martinez Santos B, Planas J, Rovira Vallves S, and Howell DJ. A Multicenter, Randomized Trial Comparing Calcium Hydroxylapatite (RADIESSE®) to Two Hyaluronic Acids (Juvéderm® and Perlane®) for Treatment of Nasolabial Folds. 205 Patients. Dermatol Surg, 2007; 33: S144-S151.
5 Based on a clinical study of 50 patients. Split face treatments of RADIESSE Volumizing Filler alone and RADIESSE Volumizing Filler mixed with 2% lidocaine were given to patients. Significant pain reduction is defined as a 2 point reduction on the Visual Analog Scale (VAS). Data on file.
6 Sundaram H, Voigts B, Beer K, Meland M. (2010) Comparison of the Rheological Properties of Viscosity and Elasticity in Two Categories of Soft Tissue Fillers: Calcium Hydroxylapatite and Hyaluronic Acid, Dermatol Surg, 36 (s3), 1859-1865.
